Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

76 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
TOFA-PREDICT study protocol: a stratification trial to determine key immunological factors predicting tofacitinib efficacy and drug-free remission in psoriatic arthritis (PsA).
Kleinrensink NJ, Perton FT, Pouw JN, Vincken NLA, Hartgring SAY, Jansen MP, Arbabi S, Foppen W, de Jong PA, Tekstra J, Leijten EFA, Spierings J, Lafeber FPJG, Welsing PMJ, Heijstek MW; TOFA-PREDICT author group. Kleinrensink NJ, et al. Among authors: spierings j. BMJ Open. 2022 Oct 10;12(10):e064338. doi: 10.1136/bmjopen-2022-064338. BMJ Open. 2022. PMID: 36216430 Free PMC article.
A randomised, open-label trial to assess the optimal treatment strategy in early diffuse cutaneous systemic sclerosis: the UPSIDE study protocol.
Spierings J, van Rhenen A, Welsing PM, Marijnissen AC, De Langhe E, Del Papa N, Dierickx D, Gheorghe KR, Henes J, Hesselstrand R, Kerre T, Ljungman P, van de Loosdrecht AA, Marijt EW, Mayer M, Schmalzing M, Schroers R, Smith V, Voll RE, Vonk MC, Voskuyl AE, de Vries-Bouwstra JK, Walker UA, Wuttge DM, van Laar JM. Spierings J, et al. BMJ Open. 2021 Mar 18;11(3):e044483. doi: 10.1136/bmjopen-2020-044483. BMJ Open. 2021. PMID: 33737437 Free PMC article.
Author Correction: Regulatory T cells in psoriatic arthritis: an IL-17A-producing, Foxp3intCD161 + RORγt + ICOS + phenotype, that associates with the presence of ADAMTSL5 autoantibodies.
Pouw JN, Olde Nordkamp MAM, van Kempen T, Concepcion AN, van Laar JM, van Wijk F, Spierings J, Leijten EFA, Boes M. Pouw JN, et al. Among authors: spierings j. Sci Rep. 2023 Jan 24;13(1):1348. doi: 10.1038/s41598-023-28623-y. Sci Rep. 2023. PMID: 36693899 Free PMC article. No abstract available.
Prognostication of progressive pulmonary fibrosis in connective tissue disease-associated interstitial lung diseases: A cohort study.
Chiu YH, Koops MFM, Voortman M, van Es HW, Langezaal LCM, Welsing PMJ, Jamnitski A, Wind AE, van Laar JM, Grutters JC, Spierings J. Chiu YH, et al. Among authors: spierings j. Front Med (Lausanne). 2023 Feb 27;10:1106560. doi: 10.3389/fmed.2023.1106560. eCollection 2023. Front Med (Lausanne). 2023. PMID: 36923009 Free PMC article.
76 results